In this podcast, Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of US surveillance data of adults with HIV infection that examined the financial barriers to antiretroviral therapy adherence. More at: www.consultant360.com/infectious-diseases.

In this podcast, Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of US surveillance data of adults with HIV infection that examined the financial barriers to antiretroviral therapy adherence. More at: www.consultant360.com/infectious-diseases.

In this podcast,&nbsp;Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of&nbsp;US surveillance data of adults with HIV infection that examined the financial barriers to antiretroviral therapy adherence. More at: www.consultant360.com/infectious-diseases.

Linda Beer, PhD, on Cost as a Barrier to ART Adherence

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Linda Beer, PhD, on Cost as a Barrier to ART Adherence

Sign up to save your podcasts

Linda Beer, PhD, on Cost as a Barrier to ART Adherence

Linda Beer, PhD, on Cost as a Barrier to ART Adherence

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast